Topical Collection on Antimicrobial Development and Drug Resistance

ISSN: 1523-3847 (Print) 1534-3146 (Online)

In this topical collection (25 articles)

previous disabled Page of 2
  1. No Access

    Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

    Resistance to Non-glycopeptide Agents in Serious Staphylococcus aureus Infections

    Kyle C. Molina, Vanthida Huang Article:47
  2. No Access

    Antimicrobial Development and Drug Resistance (K Claeys and A Vega, Section Editors)

    Antifungal Resistance: a Concerning Trend for the Present and Future

    Joshua A. Hendrickson, Chenlin Hu, Samuel L. Aitken Article:47
  3. No Access

    Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

    New Drugs in the Pipeline for the Treatment of HIV: a Review

    Leigh Anne Hylton Gravatt, Crystal R Leibrand Article:42
  4. No Access

    Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

    Echinocandin Resistance in Candida Species: a Review of Recent Developments

    Nathan P. Wiederhold Article:42
  5. No Access

    Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

    Azole Resistance in Candida glabrata

    Sarah G. Whaley, P. David Rogers Article:41
  6. No Access

    Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

    Antibiotic Resistance in Pediatric Urinary Tract Infections

    Jeremy S. Stultz, Christopher D. Doern, Emily Godbout Article:40
  7. No Access

    Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

    Updates in the Management of Cephalosporin-Resistant Gram-Negative Bacteria

    Andre Arizpe, Kelly R. Reveles, Shrina D. Patel Article:39
  8. No Access

    Antimicrobial Development and Drug Resistance (K Claeys and A Vega, Section Editors)

    Recognizing and Overcoming Resistance to New Beta-Lactam/Beta-Lactamase Inhibitor Combinations

    Stephanie Ho, Lynn Nguyen, Trang Trinh Article:39
  9. No Access

    Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

    Polymyxin Resistance in Gram-negative Pathogens

    Pavithra Srinivas, Kaitlyn Rivard Article:38
  10. No Access

    Antimicrobial Development and Drug Resistance (K Claeys and A Vega, Section Editors)

    Simplifying ARV Therapy in the Setting of Resistance

    Neha Sheth Pandit, Daniel B. Chastain Article:38
  11. No Access

    Antimicrobial Development and Drug Resistance (A Pakyz, Section Editors)

    Treatment of Vancomycin-Resistant Enterococci: Focus on Daptomycin

    Rose M. Kohinke, Amy L. Pakyz Article:33
  12. No Access

    Antimicrobial Development and Drug Resistance (K Claeys and A Vega, Section Editors)

    Antimicrobial Stewardship Interventions to Combat Antibiotic Resistance: an Update on Targeted Strategies

    Kelli A. Cole, Kaitlyn R. Rivard, Lisa E. Dumkow Article:33
  13. Antimicrobial Development and Drug Resistance (KC Claeys and J Smith, Section Editors)

    Clinical Utility of Lefamulin: If Not Now, When?

    Nicholas J. Mercuro, Michael P. Veve Article:25
  14. No Access

    Antimicrobial Development and Drug Resistance (A Pakyz, Section Editor)

    Multidrug-Resistant Pseudomonas Infections: Hard to Treat, But Hope on the Horizon?

    Lynn Nguyen, Joshua Garcia, Katherine Gruenberg Article:23
  15. No Access

    Antimicrobial Development and Drug Resistance (K Claeys and A Vega, Section Editors)

    Novel Strategies for the Management of Vancomycin-Resistant Enterococcal Infections

    German A. Contreras, Jose M. Munita, Cesar A. Arias Article:22
previous disabled Page of 2